Evidence map›Paper›PMID 36043423›Full record

ArticleESC heart failure2022

Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.

Sitong Li, Hui Wang, Tong Liu, Qifan Li, Xiuxiu Yang, Ran Xiong, Qiang Lv, Xin Du, Jianzeng Dong, Changsheng Ma

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Sitong LiDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Hui WangDepartment of Radiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tong LiuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Qifan LiDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Xiuxiu YangDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Ran XiongDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Qiang LvDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Xin DuDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Jianzeng DongDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.ORCID 0000-0001-7299-7805
Changsheng MaDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, No. 2 Anzhen Rd, Chaoyang District, Beijing, 100029, China.
Capital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 45-year-old male with cardiac sarcoidosis verified by cardiac biopsy presented with multiple coexisting arrhythmias, including ventricular tachycardia of more than 1000 episodes per 24 h, paroxysmal atrial fibrillation, and third-degree atrioventricular block. He did not respond to corticosteroids dose of 20-60 mg once daily and mycophenolate mofetil dose of 1 g twice daily for 6 months. Cardiac magnetic resonance (CMR) demonstrated inflammation and late gadolinium enhancement on right ventricular wall and interventricular septum. Positron emission tomography-computed tomography (PET-CT) showed multifocal

Indexed as

Atrioventricular BlockCardiomyopathiesMyocarditisSarcoidosisAdalimumabArrhythmias, CardiacContrast MediaFluorodeoxyglucose F18GadoliniumHumansInflammationMaleMiddle AgedMycophenolic AcidPositron Emission Tomography Computed TomographyAdalimumabContrast MediaFluorodeoxyglucose F18GadoliniumMycophenolic AcidAdalimumabCardiac magnetic resonanceCardiac sarcoidosisPositron emission tomography-computed tomographyTumour necrosis factor-α inhibitorVentricular tachycardia

Identifiers

PMID36043423
PMCPMC9773717
OpenAlexW4293740566

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.